A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
